AbCellera Biologics Inc. (ABCL) compared with its closest peers (IBRX, KYMR, LFCR, CTMX, ASMB). Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
ImmunityBio, Kymera Therapeutics, Lifecore Biomedical, CytomX Therapeutics, Assembly Biosciences, Viridian Therapeutics, Eton Pharmaceuticals, Rockwell Medical, Arcturus Therapeutics and Kura Oncology share AbCellera Biologics's sub-industry, pharmaceutical makers.
| Company | Market Cap | P/E |
|---|---|---|
| ImmunityBio, Inc. (IBRX) | $8.31B | -5.2 |
| Kymera Therapeutics, Inc. (KYMR) | $9.86B | -21.1 |
| Lifecore Biomedical, Inc. (LFCR) | $179.04M | -15.2 |
| CytomX Therapeutics, Inc. (CTMX) | $809.50M | -28.5 |
| Assembly Biosciences, Inc. (ASMB) | $748.05M | -62.0 |
| Viridian Therapeutics, Inc. (VRDN) | $2.35B | — |
| Eton Pharmaceuticals, Inc. (ETON) | $1.77B | 139.7 |
| Rockwell Medical, Inc. (RMTI) | $319.31M | — |
| Arcturus Therapeutics Holdings Inc. (ARCT) | $476.09M | -2.5 |
| Kura Oncology, Inc. (KURA) | $1.17B | -3.3 |
| Sector P/E (Healthcare) | 21.6 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
ABCL overview · ABCL earnings · ABCL financials · ABCL KPIs · ABCL documents · ABCL ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.